{"name": "Perseid Therapeutics",
 "permalink": "perseid-therapeutics",
 "crunchbase_url": "http://www.crunchbase.com/company/perseid-therapeutics",
 "homepage_url": "http://www.perseidtherapeutics.com",
 "blog_url": "",
 "blog_feed_url": "",
 "twitter_username": "",
 "category_code": "biotech",
 "number_of_employees": null,
 "founded_year": 2009,
 "founded_month": 9,
 "founded_day": null,
 "deadpooled_year": null,
 "deadpooled_month": null,
 "deadpooled_day": null,
 "deadpooled_url": null,
 "tag_list": "",
 "alias_list": "",
 "email_address": "",
 "phone_number": "650-298-5800",
 "description": "",
 "created_at": "Fri Mar 18 05:39:24 UTC 2011",
 "updated_at": "Fri Mar 18 05:44:43 UTC 2011",
 "overview": "\u003Cp\u003EPerseid Therapeutics LLC was founded in September 2009 as a joint venture between Maxygen, Inc. and Astellas Pharma Inc. to co-develop Maxygen\u00e2\u20ac\u2122s technology assets in protein pharmaceuticals, including MAXY-4, a next-generation CTLA4-Ig.  Under the terms of the agreement, Astellas received worldwide rights to commercialize MAXY-4 for autoimmune disease and transplantation.\u003C/p\u003E",
 "image":
  {"available_sizes":
    [[[150,
       63],
      "assets/images/resized/0012/6779/126779v1-max-150x150.jpg"],
     [[250,
       105],
      "assets/images/resized/0012/6779/126779v1-max-250x250.jpg"],
     [[300,
       126],
      "assets/images/resized/0012/6779/126779v1-max-450x450.jpg"]],
   "attribution": null},
 "products":
  [],
 "relationships":
  [{"is_past": false,
    "title": "CEO \u0026 President",
    "person":
     {"first_name": "Grant",
      "last_name": "Yonehiro",
      "permalink": "grant-yonehiro",
      "image":
       {"available_sizes":
         [[[142,
            150],
           "assets/images/resized/0012/6781/126781v1-max-150x150.jpg"],
          [[152,
            160],
           "assets/images/resized/0012/6781/126781v1-max-250x250.jpg"],
          [[152,
            160],
           "assets/images/resized/0012/6781/126781v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": false,
    "title": "Chief Corporate Counsel",
    "person":
     {"first_name": "John",
      "last_name": "Borkholder",
      "permalink": "john-borkholder",
      "image":
       {"available_sizes":
         [[[143,
            150],
           "assets/images/resized/0012/6782/126782v1-max-150x150.jpg"],
          [[153,
            160],
           "assets/images/resized/0012/6782/126782v1-max-250x250.jpg"],
          [[153,
            160],
           "assets/images/resized/0012/6782/126782v1-max-450x450.jpg"]],
        "attribution": ""}}},
   {"is_past": true,
    "title": "CEO",
    "person":
     {"first_name": "Rick",
      "last_name": "Feldt",
      "permalink": "rick-feldt",
      "image": null}}],
 "competitions":
  [],
 "providerships":
  [],
 "total_money_raised": "$0",
 "funding_rounds":
  [],
 "investments":
  [],
 "acquisition": null,
 "acquisitions":
  [],
 "offices":
  [{"description": "",
    "address1": "515 Galveston Drive",
    "address2": "",
    "zip_code": "94063",
    "city": "Redwood City",
    "state_code": "CA",
    "country_code": "USA",
    "latitude": null,
    "longitude": null}],
 "milestones":
  [],
 "ipo": null,
 "video_embeds":
  [],
 "screenshots":
  [{"available_sizes":
     [[[150,
        117],
       "assets/images/resized/0012/6780/126780v1-max-150x150.jpg"],
      [[250,
        196],
       "assets/images/resized/0012/6780/126780v1-max-250x250.jpg"],
      [[450,
        353],
       "assets/images/resized/0012/6780/126780v1-max-450x450.jpg"]],
    "attribution": null}],
 "external_links":
  []}